Carolina Borsoi Moraes

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development

Carolina Borsoi Moraes, Miriam A. Giardini, Hwayoung Kim et al. · Scientific Reports · 2014 · 208 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity

Bianca Zingales, Michael A. Miles, Carolina Borsoi Moraes et al. · Memórias do Instituto Oswaldo Cruz · 2014 · 140 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Hydrocephalus and arthrogryposis in an immunocompetent mouse model of ZIKA teratogeny: A developmental study

José Xavier‐Neto, Murilo de Carvalho, Bruno dos Santos Pascoalino et al. · PLoS neglected tropical diseases · 2017 · 111 citations · Full text

Life Sciences, Developmental Biology, Infectious Diseases +15

Bacteria from Antarctic environments: diversity and detection of antimicrobial, antiproliferative, and antiparasitic activities

Tiago Rodrigues e Silva, Alysson Wagner Fernandes Duarte, Michel Rodrigo Zambrano Passarini et al. · Polar Biology · 2018 · 75 citations

Life Sciences, Microbiology, Environmental Microbiology +13

Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity

F. Di Pisa, Giacomo Landi, Lucia Dello Iacono et al. · Molecules · 2017 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15